Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | Anemia | Case report

Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report

Authors: Sandra Simony Tornoe Riis, Marianne Hoerby Joergensen, Kristina Fruerlund Rasmussen, Steffen Husby, Jane Preuss Hasselby, Lise Borgwardt, Klaus Brusgaard, Christina Ringmann Fagerberg, Henrik Thybo Christesen

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anemia and unconjugated hyperbilirubinemia. In past reports, transient congenital hyperinsulinism has been described as a rare complication of rhesus D alloimmunization. Our case report illustrates that rhesus D alloimmunization can result in a pseudosyndrome with severe congenital hyperinsulinism, anemia, and conjugated hyperbilirubinemia, despite correctly administered anti-D immunoglobulin prophylaxis.

Case presentation

We report of a 36-year-old, Caucasian gravida 1, para 1 mother with A RhD negative blood type who received routine antenatal anti-D immunoglobulin prophylaxis. Her full term newborn boy presented with severe congenital hyperinsulinism, anemia, and conjugated hyperbilirubinemia up to 295 µmol/L (ref. < 9), accounting for 64% of the total bilirubin. Syndromic congenital hyperinsulinism was suspected. Examinations showed a positive direct antiglobulin test, initially interpreted as caused by irregular antibodies; diffuse congenital hyperinsulinism by 18F-DOPA positron emission tomography/computed tomography scan; normal genetic analyses for congenital hyperinsulinism; mildly elevated liver enzymes; delayed, but present bile excretion by Tc99m-hepatobiliary iminodiacetic acid scintigraphy; and cholestasis and mild fibrosis by liver biopsy. The maternal anti-D titer was 1:16,000 day 20 postpartum. Y-chromosome material in the mother’s blood could not be identified. This could, however, not exclude late intrapartum fetomaternal hemorrhage as the cause of immunization. No causative genetic findings were deetrmined by trio whole exome sequencing. The child went into clinical remission after 5.5 months.

Conclusion

Our case demonstrates that rhesus D alloimmunization may present as a pseudosyndrome with transient congenital hyperinsulinism, anemia, and inspissated bile syndrome with conjugated hyperbilirubinaemia, despite anti-D immunoglobulin prophylaxis, possibly due to late fetomaternal hemorrhage.
Literature
1.
go back to reference Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr. 2015;167(2):238–45.CrossRef Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr. 2015;167(2):238–45.CrossRef
2.
go back to reference Lucey JF, Randall JL, Murray JJ. Is hypoglycemia an important complication in erythroblastosis fetalis? Am J Dis Child. 1967;114:88–90.PubMed Lucey JF, Randall JL, Murray JJ. Is hypoglycemia an important complication in erythroblastosis fetalis? Am J Dis Child. 1967;114:88–90.PubMed
3.
go back to reference Smits-Wintjens VEHJ, Rath MEA, Lindenburg ITM, Oepkes D, van Zwet EW, Walther FJ, et al. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome. Neonatology. 2012;101:306–10.CrossRef Smits-Wintjens VEHJ, Rath MEA, Lindenburg ITM, Oepkes D, van Zwet EW, Walther FJ, et al. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome. Neonatology. 2012;101:306–10.CrossRef
4.
go back to reference Improdaa N, Shaha P, Güemesa M, Gilberta C, Morgana K, Sebireb N, et al. Hepatocyte nuclear factor-4 alfa mutation associated with hyperinsulinaemic hypoglycaemia and atypical renal Fanconi syndrome: expanding the clinical phenotype. Horm Res Paediatr. 2016;86:337–41.CrossRef Improdaa N, Shaha P, Güemesa M, Gilberta C, Morgana K, Sebireb N, et al. Hepatocyte nuclear factor-4 alfa mutation associated with hyperinsulinaemic hypoglycaemia and atypical renal Fanconi syndrome: expanding the clinical phenotype. Horm Res Paediatr. 2016;86:337–41.CrossRef
6.
go back to reference Koelewijn JM, de Haas M, Vrijkotte TGM, Bonsel GJ, van der Schoot CE. One single dose of 200 mg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion. 2008;48:1721–9.CrossRef Koelewijn JM, de Haas M, Vrijkotte TGM, Bonsel GJ, van der Schoot CE. One single dose of 200 mg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion. 2008;48:1721–9.CrossRef
7.
go back to reference Taba R, Yamakawa M, Miyakoshi C, Imai Y. Refractory cholestasis presenting as cholangiolitis in an Rh (E)-incompatible neonate. J Paediatr Child Health. 2010;48(3):126–31.CrossRef Taba R, Yamakawa M, Miyakoshi C, Imai Y. Refractory cholestasis presenting as cholangiolitis in an Rh (E)-incompatible neonate. J Paediatr Child Health. 2010;48(3):126–31.CrossRef
8.
go back to reference Stanley CA, Rozance PJ, Thornton PS, Leon DD, Harris D, Haymond MW, et al. Re-evaluating “transitional neonatal hypoglycemia”: mechanism and implications for management. J Pediatr. 2015;167(6):1520–5.CrossRef Stanley CA, Rozance PJ, Thornton PS, Leon DD, Harris D, Haymond MW, et al. Re-evaluating “transitional neonatal hypoglycemia”: mechanism and implications for management. J Pediatr. 2015;167(6):1520–5.CrossRef
9.
go back to reference Feller JM, Simpson AM, Nelson M, Swan AM, O’Connell PJ, Hawthorne WJ, et al. Growth-promoting effect of Rh(D) antibody on human pancreatic islet cells. J Clin Endocrinol Metab. 2008;93(9):3560–7.CrossRef Feller JM, Simpson AM, Nelson M, Swan AM, O’Connell PJ, Hawthorne WJ, et al. Growth-promoting effect of Rh(D) antibody on human pancreatic islet cells. J Clin Endocrinol Metab. 2008;93(9):3560–7.CrossRef
Metadata
Title
Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report
Authors
Sandra Simony Tornoe Riis
Marianne Hoerby Joergensen
Kristina Fruerlund Rasmussen
Steffen Husby
Jane Preuss Hasselby
Lise Borgwardt
Klaus Brusgaard
Christina Ringmann Fagerberg
Henrik Thybo Christesen
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Anemia
Published in
Journal of Medical Case Reports / Issue 1/2021
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-03167-9

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue